Advancements in diagnostics, drug discovery, and ecology have increased the popularity of high-throughput assays for rapidly screening many samples. This shift has brought about the need for practical, cost-effective methods to scale assays while ensuring consistent, reliable results. Assay miniaturization has proven to be a game-changer by helping scientists and clinicians achieve greater assay scalability with smaller sample volumes1. However, miniaturization also introduces challenges with sample preparation, reaction miniaturization, and signal detection. Here, we will explore strategies for miniaturized assay optimization to address these challenges effectively.
There are five key advantages to assay miniaturization.
Miniaturized assay optimization begins with sample preparation. Tiny volumes must be sufficiently concentrated to avoid compromising results. Precise handling of these small volumes is also tricky, with slight errors impacting assay accuracy. Strategies to optimize sample preparation can help researchers address these issues, including:
Reaction miniaturization is also a key component of effective assay scaling down. Assay optimization strategies for reaction miniaturization include:
Figure 1. Automating dispensing with the I.DOT Liquid Handler is a great strategy for miniaturization assay optimization.
Finally, assay optimization includes selecting the most appropriate detection method(s). Generally, this will be the method that enables the highest precision and sensitivity while being compatible with the miniaturized, high-throughput assay format6. Detection method assay optimization strategies include:
Even with the most thorough assay optimization, researchers often face miniaturization challenges, and techniques for overcoming these are essential. First, maintaining an optimal signal-to-noise ratio is crucial and can be achieved by refining detection methods to enhance sensitivity and specificity and employing strategies to minimize non-specific binding. Additionally, results from miniaturized assays need to be easily transferable to larger-scale experiments. Finally, validation and quality control are as essential in miniaturized assays as they are for their larger-scale counterparts. Adapting validation strategies may include developing new calibration protocols, implementing rigorous controls, and ensuring assay reproducibility and reliability.
Miniaturized assays have the potential to revolutionize diagnostics and research by facilitating enhanced scalability, sensitivity, and cost-efficiency. Overcoming challenges in sample preparation, reaction miniaturization, and detection through advanced assay optimization and validation technologies are crucial in enabling their successful application.
Are you looking for effective assay optimization strategies? Book a consultation with one of our experts today to find out how DISPENDIX’s I.DOT Liquid Handler can help accelerate your research, enabling assay miniaturization with more reliable, reproducible results than ever before.
Pereira SAP, Dyson PJ, Saraiva MLMFS. Miniaturized technologies for high-throughput drug screening enzymatic assays and diagnostics – A review. TrAC Trends Anal Chem. 2020;126:115862. doi:10.1016/j.trac.2020.115862
Bosco A, Ambrosetti E, Mavri J, Capaldo P, Casalis L. Miniaturized Aptamer-Based Assays for Protein Detection. Chemosensors. 2016;4(3):18. doi:10.3390/chemosensors4030018
Guzman NA, Guzman DE, Blanc T. Advancements in portable instruments based on affinity-capture-migration and affinity-capture-separation for use in clinical testing and life science applications. J Chromatogr A. 2023;1704:464109. doi:10.1016/j.chroma.2023.464109
Ortseifen V, Viefhues M, Wobbe L, Grünberger A. Microfluidics for Biotechnology: Bridging Gaps to Foster Microfluidic Applications. Front Bioeng Biotechnol. 2020;8:589074. doi:10.3389/fbioe.2020.589074
Silva TC, Eppink M, Ottens M. Automation and miniaturization: enabling tools for fast, high‐throughput process development in integrated continuous biomanufacturing. J Chem Technol Biotechnol. 2022;97(9):2365-2375. doi:10.1002/jctb.6792
Kricka LJ, Park JY, Li SF, Fortina P. Miniaturized detection technology in molecular diagnostics. Expert Rev Mol Diagn. 2005;5(4):549-559. doi:10.1586/14737159.5.4.549
Ahmad R, Ahsan H. Emerging technology of multiplexing in clinical diagnostics. Int J Health Sci. 2022;16(2):1-2.
Basu AS. Digital Assays Part II: Digital Protein and Cell Assays. SLAS Technol. 2017;22(4):387-405. doi:10.1177/2472630317705681